Premier Path Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Premier Path Wealth Partners's BMY Position: Q3 2026 in Review
Premier Path Wealth Partners increased its Bristol-Myers Squibb (BMY) stake by 9.6% in Q3 2026, buying an estimated $172K and bringing the position to 30,934 shares worth $1.93M. The position accounts for 0.23% of the portfolio, ranked #101.
Premier Path Wealth Partners first reported a position in BMY in Q4 2023 and has held it in 12 quarters since. The position peaked at $2.04M in Q1 2025. 694 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Premier Path Wealth Partners held 30,934 shares of Bristol-Myers Squibb worth $1.93M as of Q3 2026.
- Premier Path Wealth Partners bought 2,715 Bristol-Myers Squibb shares in Q3 2026, an estimated $172K.
- Bristol-Myers Squibb made up 0.23% of Premier Path Wealth Partners's portfolio in Q3 2026, its #101 holding.
- Premier Path Wealth Partners first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 12 quarters since.
- Premier Path Wealth Partners's Bristol-Myers Squibb position peaked at $2.04M in Q1 2025.
- 694 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Premier Path Wealth Partners's 13F filing for Q3 2026, filed 16 Oct 2026.